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Abstract
Background: Excess consumption of energy-dense, high-fat Western diets contributes to the development of
obesity and obesity-related disorders, such as fatty liver disease. However, not only the quantity but also the
composition of dietary fat may play a role in the development of liver steatosis. The aim of this study was to
determine the effects of low-stearate palm oil and high-stearate lard high-fat diets on in vivo liver lipid metabolism.
Methods: Wistar rats were fed with either normal chow (CON), a high-fat diet based on palm oil (HFP), or a
high-fat diet based on lard (HFL). After 10 weeks of diet, magnetic resonance spectroscopy was applied for the in
vivo determination of intrahepatocellular lipid content and the uptake and turnover of dietary fat after oral
administration of 13C-labeled lipids. Derangements in liver lipid metabolism were further assessed by measuring
hepatic very-low density lipoprotein (VLDL) secretion and ex vivo respiratory capacity of liver mitochondria using
fat-derived substrates. In addition, whole-body and hepatic glucose tolerance were determined with an
intraperitoneal glucose tolerance test.
Results: Both high-fat diets induced liver lipid accumulation (p < 0.001), which was accompanied by a delayed
uptake and/or slower turnover of dietary fat in the liver (p < 0.01), but without any change in VLDL secretion rates.
Surprisingly, liver lipid content was higher in HFP than in HFL (p < 0.05), despite the increased fatty acid oxidative
capacity in isolated liver mitochondria of HFP animals (p < 0.05). In contrast, while both high-fat diets induced
whole-body glucose intolerance, only HFL impaired hepatic glucose tolerance.
Conclusion: High-fat diets based on palm oil and lard similarly impair the handling of dietary lipids in the liver,
but only the high-fat lard diet induces hepatic glucose intolerance.
Keywords: Diet and dietary lipids, Fatty acid metabolism, Fatty acid oxidation, Insulin resistance,
Magnetic resonance spectroscopy, Mitochondria, Nutrition, Obesity, Triglycerides, VLDL
Background
A sedentary lifestyle and excess consumption of energy-
dense Western diets contribute to the development of
obesity and obesity-related disorders, such as insulin re-
sistance and type 2 diabetes, dyslipidaemia, hypertension,
cardiovascular disease, and fatty liver disease [1–3]. In
obesity, the excessive amount of triglycerides (TG) is
stored not only in adipose tissue, but also in muscle, liver,
pancreas, and heart, which is referred to as ectopic lipid
deposition [4, 5]. Hepatic steatosis is a hallmark of non-
alcoholic fatty liver disease (NAFLD), the most common
liver disorder in the Western world, which can evolve into
non-alcoholic steatohepatitis (NASH), liver cirrhosis, and
hepatocellular carcinoma [6–8]. The main pathways in
hepatic lipid metabolism are uptake of fatty acids derived
from dietary fat and adipose tissue TG, de novo lipogen-
esis, oxidation of fatty acids, and secretion of very-low
density lipoproteins (VLDL). Hepatic steatosis occurs
when the rate of uptake and synthesis of fatty acids by
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hepatocytes exceeds the rate of oxidation and secre-
tion [7, 9, 10].
The metabolic fate of fatty acids depends on chain
length, degree of saturation, and the stereoisomeric
configuration of double bonds [11–15]. Therefore, diet-
ary fats with different fatty acid compositions may differ-
entially affect hepatic lipid metabolism. Data from the
National Health and Nutrition Examination Survey
(NHANES) show that from the fat consumed by the US
population about one-third is saturated fat [16], with
palmitic acid (C16:0) and stearic acid (C18:0) accounting
for the majority of saturated fatty acid intake [17]. The
efficiency of oxidation of fatty acids decreases with in-
creasing chain length and it has been shown that stearic
acid is poorly oxidized by hepatocytes [18–21]. More-
over, it has been reported that stearate is a poor sub-
strate for the esterification into TG and subsequent
VLDL synthesis and secretion [22, 23]. Dietary fatty
acids have also been shown to affect insulin sensitivity in
a chain-length dependent manner [24]. Mice receiving a
high-fat diet based on lard developed both hepatic and
peripheral insulin resistance, whereas mice fed with a
high-fat diet based on palm oil developed peripheral in-
sulin resistance only [25]. The two high-fat diets differed
largely in the content of stearate, with the lard diet con-
taining about 3-fold more stearate than the palm oil diet.
Moreover, it was demonstrated that when the palm oil
diet was supplemented with tristearin (to the stearate
level of the lard based diet) hepatic insulin sensitivity
was similarly impaired as with the lard diet, showing
that this effect can be attributed to stearate per se [25].
Because of the low efficiency for oxidation and secretion,
diets rich in stearate may more rapidly induce hepatic
steatosis as compared with palmitate, which could con-
tribute to hepatic insulin resistance through lipid-
induced mechanisms [26]. However, the exact effects of
stearate versus palmitate on hepatic lipid metabolism are
currently not known.
Proton magnetic resonance spectroscopy (1H MRS)
has proven to be a valuable tool for the non-invasive
quantification of intrahepatocellular lipids (IHCL) [27–29].
Although it is a very powerful method to detect hepatic
steatosis, it cannot discriminate between disturbances in
lipid accretion on one hand and lipid utilization on the
other. For this purpose, we previously introduced the ap-
plication of proton-observed, carbon-edited (1H-[13C])
MRS in combination with the oral administration of 13C-
labeled lipids [30, 31]. Using this method it is possible to
determine in vivo and at multiple time points the amount
of diet-derived 13C-labeled lipids in the liver, which gives
information on the time course of uptake and utilization
of dietary lipids.
The aim of this study was to determine the effects of
low-stearate palm oil and high-stearate lard high-fat diets
on liver lipid metabolism and glucose tolerance in rats.
Wistar rats were fed a high-fat diet based on palm oil or a
high-fat diet based on lard for a period of 10 weeks. 1H-
[13C] MRS was used for the in vivodetermination of total
IHCL content and the 13C enrichment of IHCL at baseline
and 4 h and 24 h after the oral administration of 13C-la-
beled lipids. Derangements in liver lipid utilization were
further assessed by measuring hepatic VLDL-TG secretion
rates and ex vivo respiratory capacity of liver mitochondria
using fat-derived substrates. In addition, we determined
whole-body and hepatic glucose tolerance.
Methods
Animals and diets
Adult male Wistar rats (348.2 ± 1.5 g, 11 weeks of
age, n = 60; Charles River Laboratories, The Netherlands)
were housed in pairs at 20 °C and 50 % humidity on a
12 h light-dark cycle with ad libitum access to food and
water. After one week of acclimatization the rats were
equally divided into three groups: a control group receiv-
ing normal chow (CON; 9 energy percent (En%) from fat,
67 En% from carbohydrates, 24 En% from protein; R/M-H
diet, Ssniff Spezialdiäten GmbH, Soest, Germany), a sec-
ond group receiving a high-fat palm oil diet (HFP; 45 En%
from fat (39.4 En% from palm oil and 5.5 En% from
soybean oil), 35 En% from carbohydrate, 20 En% from
protein; Research Diet Services, Wijk bij Duurstede, The
Netherlands), and a third group receiving a high-fat lard
diet (HFL; 45 En% from fat (39.4 En% from lard and 5.5
En% from soybean oil), 35 En% from carbohydrate, 20
En% from protein; Research Diet Services, Wijk bij
Duurstede, The Netherlands). In a previous study, the fatty
acid composition of the total fat content of the high-fat
diets was determined and details can be found in Table 2
of reference [25]. Based on these data, the high-fat palm
oil diet contained 16 En% of palmitate (C16:0) and 2 En%
of stearate (C18:0), while the high-fat lard diet con-
tained 13 En% of palmitate (C16:0) and 7 En% of stearate
(C18:0). Otherwise, fatty acid composition of the two
high-fat diets was similar, except for linoleic acid
(C18:2w6), which was more abundant in the high-fat palm
oil diet as compared with the high-fat lard diet (7 En%
versus 4 En%). It should be noted though that the high-fat
diets used in the current study were from a different batch
and therefore the fatty acid composition may slightly dif-
fer. Body weight and food intake were determined weekly.
All rats received the diet for a period of 10 weeks, after
which each dietary group was divided into two subgroups:
one group (n = 9 per diet group) for MRS measurements
and oxygen consumption measurements of isolated liver
mitochondria, and one group (n = 11 per diet group) for
intraperitoneal glucose tolerance tests (ipGTT) with deu-
terated glucose and determination of hepatic VLDL-TG
secretion rates. All animal experiments were reviewed and
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approved by the Animal Ethics Committee of Maastricht
University, The Netherlands.
MRS experiments
To determine total (12C + 13C) IHCL content and natural
abundance 13C enrichment of IHCL in liver after 10 weeks
of diet, animals (n = 9 per diet group) were subjected to
baseline 1H-[13C] MRS measurements. Two days later,
rats received 1.5 g [U-13C] labeled algal lipid mixture (13C
enrichment > 98 %; fatty acid composition: 53 % palmitic
acid, 9 % palmitoleic acid, 28 % oleic acid, and 6 % linoleic
acid; Buchem B.V., Apeldoorn, The Netherlands) per kg
body weight orally. The following 4 h the rats remained
fasted, after which 1H-[13C] MRS experiments were per-
formed to determine 13C-enriched IHCL concentrations.
Between 4 and 24 h after 13C-labeled lipid administration,
the high-fat diet groups were pairwise fed with CON rats
and therefore all rats consumed the same amount of
calories. At 24 h, the final 1H-[13C] MRS experiments
were performed. Blood samples were taken from the vena
saphena after each MRS experiment and were collected in
paraoxon-coated capillaries, to prevent lipolysis [32]. The
samples were centrifuged at 1000 g for 10 min and plasma
was frozen in liquid nitrogen and stored at -80 °C for the
analysis of non-esterified fatty acids (NEFA) using the
NEFA-HR(2) kit (Wako Chemicals, Neuss, Germany).
After the last MRS measurement at 24 h, animals were
euthanized by incising the vena cava inferior, and the
median liver lobe was excised and used for the isolation of
liver mitochondria.
During the MRS experiments, animals were anaesthe-
tized using 1.5–2.5 % isoflurane (IsoFlo®; Abbott Labora-
tories Ltd, Maidenhead, Berkshire, UK). Body temperature
was maintained at 37 ± 1 °C using heating pads. Respir-
ation was monitored with a respiratory balloon and the
respiration period was kept between 700 and 1200 ms. All
MRS experiments were executed on a 6.3 T horizontal
Bruker MR system (Bruker, Ettlingen, Germany). Local-
ized 1H-[13C] MRS was performed on a 4x2x4 mm3 voxel
in the median lobe of the liver using the LASER-POCE
method as described previously [30]. Briefly, 3D lo-
calization of a voxel in the liver was achieved by the
LASER (localization by adiabatic selective refocusing)
sequence [33], which was combined with a POCE
(proton-observed, carbon-edited) element [34, 35] for
13C editing. The 13C-editing pulse was centered on
the lipid methylene resonance, as determined from an
unlocalized 13C spectrum. For each voxel, 64 LASER-
POCE experiments, consisting of 16 averages each,
were performed serially in an interleaved fashion with
the 13C-editing pulse turned on every other experi-
ment. Water suppression was achieved using SWAMP
(sequence for water suppression with adiabatic modu-
lated pulses) [36]. As an internal reference, an
unsuppressed water spectrum, consisting of 16 averages,
was recorded from the same voxel. Other LASER-POCE
parameters were as follows: TR = 2000 ms, TE = 26.8 ms,
TEPOCE = 7.9 ms, number of data points = 640, WALTZ-
16 13C decoupling, and total scan time = 34 min.
Spectra from the 32 LASER-POCE experiments with
and without the 13C-editing pulse were added separately,
and the difference spectrum was calculated using Matlab
(R2010a, Mathworks, Natick, MA, USA). Water and IHCL
methylene (at 1.3 ppm) peak areas were quantified from
the unsuppressed and suppressed spectra, respectively,
using a nonlinear least-squares algorithm (AMARES) in
the jMRUI software package. Total (12C + 13C) and 13C-la-
beled IHCL levels were calculated from the LASER-POCE
spectra without 13C editing and the difference spectra,
respectively, and are expressed as a percentage of the un-
suppressed water signal measured in the same voxel. The
average relative 13C enrichment determined at baseline
was used to correct the absolute 13C-labeled IHCL levels
at 4 and 24 h after 13C-labeled lipid administration for nat-
ural abundance of 13C, yielding the amount of lipids stored
in the liver originating from the administered 13C-labeled
lipids.
Isolation of liver mitochondria
Liver mitochondria were isolated using a standard differ-
ential centrifugation procedure as described elsewhere
[37]. Briefly, 1.13 ± 0.01 g of the excised median liver
lobe (n = 27) was washed in ice cold 0.9 % KCl, removed
from connective and adipose tissue, minced with scissors
in medium A (250 mM sucrose, 10 mM Tris, 3 mM
EGTA and 2 mg/ml BSA, pH 7.7 at 4 °C) and homoge-
nized using a Potter-Elvehjem homogenizer. The hom-
ogenate was centrifuged at 800 g for 10 min at 4 °C. The
supernatant was centrifuged at 7200 g for 10 min at 4 °C
and the pellet was then resuspended in ice cold medium
B (250 mM sucrose and 5 mM Tris, pH 7.3 at 4 °C) and
centrifuged at 7200 g for 10 min at 4 °C. The mitochon-
drial pellet was resuspended in 250 μl of medium B. Pro-
tein content was determined using the BCA protein
assay kit (Pierce, Thermo Fisher Scientific Inc., Rockford,
IL, USA).
Mitochondrial oxygen consumption rates
Oxygen consumption rates in isolated liver mitochondria
were measured at 37 °C using a two-channel high-
resolution Oroboros oxygraph-2 k (Oroboros, Innbruck,
Austria). Mitochondria were incubated in assay medium
containing 0.5 mM EGTA, 3 mM MgCl.6H2O, 60 mM K-
lactobionate, 20 mM taurine, 10 mM KH2PO4, 20 mM
HEPES, 110 mM sucrose, and 1 g∙l-1 BSA essentially fatty
acid free, pH 7.1 at 30 °C. All measurements were perfor-
med in 2 ml of assay medium containing 20 μl of solution
containing mitochondria. The following oxidizable
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substrates were used: (i) 5 mM pyruvate plus 5 mM mal-
ate (TCA cycle substrate), (ii) 25 μM palmitoyl-L-
carnitine plus 2.5 mM malate (β-oxidation substrate inde-
pendent of carnitine palmitoyltransferase 1 (CPT1)), and
(iii) 25 μM palmitoyl-CoA plus 2.5 mM L-carnitine plus
2.5 mM malate (β-oxidation substrate dependent on
CPT1). State 3 respiration, i.e. maximal ADP-stimulated
oxygen consumption rate, was determined after adding
4.8 U∙ml-1 hexokinase, 12.5 mM glucose, and 1 mM ATP.
State 4 respiration, i.e. basal oxygen consumption rate,
was determined after the addition of 1.25 μM carboxya-
tractyloside (CAT) to fully block ATP synthesis. Respira-
tory control ratio (RCR) was calculated by dividing oxygen
consumption rate in state 3 by oxygen consumption rate
in state 4. Data acquisition and analysis was performed
using DatLab software version 4.3 (Oroboros, Innsbruck,
Austria).
ipGTT with deuterated glucose
An intraperitoneal glucose tolerance test (ipGTT) was
performed after 10 weeks of diet (n = 11 per diet group).
After an overnight fast, rats received an intraperitoneal
injection of glucose (1 mg/g body weight containing
50 % [6,6-2H2] glucose and 50 % glucose; in a 50 mg/ml
concentration). Blood samples were taken from the vena
saphena just before and at 7.5, 15, 30, 45, 60, 90 and
120 min after the injection. [6,6-2H2] glucose was > 98 %
enriched (Buchem B.V., Apeldoorn, The Netherlands).
Blood glucose concentration was determined using a
glucose analyzer (Hemocue Diagnostics B.V., Waalre,
The Netherlands).
Blood samples for analysis of insulin concentration
were centrifuged at 1000 g for 10 min. The plasma
aliquots were then frozen in liquid nitrogen and stored
at -80 °C until analysis, which was performed using the
Ultra Sensitive Rat Insulin ELISA kit (Crystal Chem, Inc.
Downers Grove, IL, USA). The homeostatic model as-
sessment for insulin resistance (HOMA-IR) index was
calculated by multiplying fasting glucose and fasting
insulin divided by 22.5 [38].
For the determination of plasma [6,6-2H2] glucose
enrichment, blood was spotted onto filter paper (Sample
Carrier Paper FT-2-460-460570, Sartorius, Goettingen,
Germany). The dried blood spot was punched out from
the middle area of the blood spot directly into a vial.
Plasma glucose enrichments were determined as de-
scribed previously [39, 40]. In short, plasma was deprotei-
nized with 1 ml of methanol and evaporated after which
the extract was derivatized to the glucose aldonitrile pen-
taacetate form. A sample of 1 μl was injected into the gas
chromatograph/mass spectrometer (HP 6890 II GC
System and 5973 Mass Selective Detector, Agilent Tech-
nologies, Palo Alto, CA, USA). Separation was achieved
on a J&W DB17 capillary column (30 m × 0.25 mm ×
0.25 μm; J&W Scientific, Folsom, CA, USA). Mass-over-
charge ratios of 187, 188, and 189 were monitored in se-
lective ion monitoring mode, from which the percentage
of unlabeled and [6,6-2H2] glucose was calculated based
on the theoretical isotopic distribution via multiple linear
regression.
Areas under the ipGTT curves for plasma glucose
(AUCg), insulin (AUCi), deuterated glucose (AUCd2g), and
glucose enrichment (AUCEN) were calculated. In order
to analyze the glucose enrichment (EN, % 2H2-glucose
of total glucose) in more detail, a two equally sized-
compartment model was used, roughly representing the
intraperitoneal and the blood compartments, in Matlab.
The model was then fitted to the glucose enrichment data
at the different time points to estimate the peak height
and peak time of plasma glucose enrichment.
Hepatic VLDL-TG secretion rate
Two days after the ipGTT, rats were fasted for 4 h after
which they were anaesthetized and given an intravenous
injection of 400 mg/kg bodyweight Triton WR1339
(10 % (w/w) solution in phosphate buffered saline (PBS);
Sigma-Aldrich, Zwijndrecht, The Netherlands) in the tail
vein to inhibit lipoprotein lipase activity (and thereby
blocking lipolysis). Animals remained anaesthetized
during the whole experiment using 1.5-2.5 % isoflurane
(IsoFlo®; Abbott Laboratories Ltd, Maidenhead, Berkshire,
UK). Blood samples were taken from the vena saphena
before and 30, 60, 90, 120 and 150 min after the injection
of Triton WR1339 and plasma TG concentrations were
determined at the different time points using the serum
TG determination kit (Sigma-Aldrich, Zwijndrecht, The
Netherlands). Hepatic VLDL-TG secretion rate was deter-
mined from the slope of a linear fit through the
plasma TG versus time data and was corrected for body
weight [41].
Statistical analysis
Data are expressed as means ± standard error of the
mean (SEM). Time course data of body weight, energy
intake, 13C enrichment of IHCL, and plasma glucose,
2H2-glucose, glucose enrichment and insulin during the
ipGTT were analyzed using mixed-model repeated-
measures analysis of variance (ANOVA) with time point
as the within-subjects factor and diet type (CON, HFP,
and HFL) as the between-subjects factor, with Bonferroni
corrected post-hoc tests. In case of a significant inter-
action term between time and diet, the effect of time
was analyzed using a paired t-test (only for 13C en-
richment of IHCL; for the other data time effects
were not further analyzed) and differences between diets
were evaluated by one-way ANOVA with Tukey HSD
post-hoc analysis. The other data were analyzed using
one-way ANOVA with Tukey HSD post-hoc analyses.
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Statistical analyses were performed using the IBM SPSS
statistics 21 software package (SPSS Inc.; Chicago, IL,
USA). Level of significance was set at p < 0.05.
Results
Animal characteristics
Figure 1 shows body weight and energy intake of the rats
during the time course of the diets and Table 1 summa-
rizes the animal characteristics over the 10-week diet
period. Before the start of the diets, there was no differ-
ence in body weight between groups (Table 1). One week
after starting the diets body weight was already higher in
both high-fat diet groups and body weight remained
higher in the high-fat diet groups compared with CON
throughout the entire diet period, which was accompanied
by a higher energy intake (Fig. 1; Table 1). However, there
was no difference in body weight gain or energy intake be-
tween the two high-fat diet groups. After 10 weeks of diet,
animals from the two high-fat diet groups had higher liver
weights than CON animals (HFP vs. CON: p = 0.005; HFL
vs. CON: p = 0.013), but liver weight did not differ be-
tween HFP and HFL animals. Plasma NEFA concentra-
tions were not different between the three diet groups.
Magnetic resonance spectroscopy
Figure 2a displays typical examples of unedited 1H MR
spectra acquired from the liver of animals from each diet
group after 10 weeks of diet feeding, from which total
IHCL content was determined. Both high-fat diets re-
sulted in an elevated IHCL content compared with CON
(p < 0.001; Fig. 2c). Moreover and surprisingly, IHCL
content in HFP animals was higher than in HFL animals
(p < 0.05).
Figure 2b shows an example of 1H MR spectra with
and without 13C editing acquired from the liver of a HFL
rat at 24 h after 13C-labeled lipid administration, and the
calculated difference spectrum, from which the 13C
enrichment of IHCL was determined. The relative 13C en-
richment of IHCL before the administration of 13C-labeled
lipids was not different between groups and was 1.23 ±
0.07 % on average (not shown). After correction for this
natural abundance 13C enrichment, the absolute 13C-la-
beled IHCL content determined at 4 h after the adminis-
tration of the 13C-labeled lipids was significantly lower in
both high-fat diet groups compared with CON (p < 0.01;
Fig. 2d). In CON, 13C-labeled IHCL content decreased
2.5-fold between 4 and 24 h after 13C-labeled lipid admin-
istration (p < 0.01). In contrast, between 4 and 24 h 13C-la-
beled IHCL content increased 3.5-fold in HFP (p < 0.001)
and 1.9-fold in HFL (p < 0.05).
Mitochondrial function
Oxygen consumption rates in isolated liver mitochondria
oxidizing the glucose-derived substrate pyruvate plus
malate were not different between diet groups (Table 2).
In contrast, with the fat-derived substrates palmitoyl-L-
carnitine plus malate and palmitoyl-CoA plus L-carnitine
plus malate, state 3 oxygen consumption rates were higher
in HFP comparted with CON (p < 0.05), while state 4 res-
piration was not different. Mitochondrial respiration with
the fat-derived substrates was not significantly different in
HFL compared with CON.
Hepatic VLDL triglyceride secretion rate
Fasting plasma TG concentrations were higher in HFP
animals compared with CON (p < 0.01) and HFL (p <
0.05) animals (Fig. 3a). After the administration of
Triton WR1339, plasma TG concentrations increased
linearly over time (mean R2 = 0.950 ± 0.008). Hepatic
VLDL-TG secretion rates, as determined from the slope
Fig. 1 Body weight and energy intake during diet period. Body weight (a) and energy intake (b) of rats on normal chow control diet (●), high-fat
palm oil diet (∇), and high-fat lard diet ( ) determined weekly (n = 20 per group). Data are expressed as mean ± SEM. # p < 0.01, ## p < 0.001 vs.
HFP and HFL
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of the plasma TG concentrations versus time after admin-
istration of Triton WR1339, were however not affected by
high-fat diet feeding (Fig. 3b).
ipGTT with deuterated glucose
Data of the ipGTT with deuterated glucose are shown in
Fig. 4 and the results are summarized in Table 3. Fasting
plasma glucose was about 40 % higher in both high-fat
diet groups compared with CON (p < 0.01; Table 3). The
AUGg was also higher in both HFP and HFL when com-
pared with CON (p < 0.001) and, furthermore, AUGg
was higher in HFL than in HFP (p < 0.01). These results
indicate the development of whole-body glucose intoler-
ance in HFP and, to a larger extent, in HFL. Fasting
plasma insulin was almost 3-fold higher in both high-fat
diet groups compared with CON (p < 0.01) and the
Table 1 Animal characteristics
CON (n = 20) HFP (n = 20) HFL (n = 20)
Bodyweight before
diet (g)
350 ± 2 348 ± 3 347 ± 3
Body weight after diet (g) 434 ± 3 513 ± 6 *** 522 ± 4 ***
Body weight gain (g) 84 ± 3 165 ± 6 *** 175 ± 4 ***
Energy intake (kJ/week) 2181 ± 15 2601 ± 45 *** 2613 ± 23 ***
Liver weight (g) 11.9 ± 0.2 12.9 ± 0.2 ** 12.8 ± 0.2 *
Plasma NEFA (mM) 0.53 ± 0.02 0.53 ± 0.03 0.59 ± 0.03
Data are expressed as mean ± SEM. CON, normal chow control diet; HFP,
high-fat palm oil diet; HFL, high-fat lard diet; NEFA, non-esterified fatty acid
measured after 10 weeks of diet (n = 9 per diet group). * p < 0.05, ** p < 0.01,
*** p < 0.001 vs. CON
Fig. 2 Determination of total IHCL content and 13C enrichment of IHCL by MRS. Typical examples of unedited LASER-POCE spectra acquired from
the liver of animals from each diet group after 10 weeks of diet feeding (a), and LASER-POCE spectra with and without 13C editing acquired from
the liver of a HFL rat at 24 h after 13C-labeled lipid administration, together with the calculated difference spectrum containing only 13C-coupled
1H resonances (5x magnification) (b). Total lipid content at baseline (c) and absolute 13C-labeled IHCL content corrected for 13C natural abundance
at 4 and 24 h after the oral administration of [U-13C] algal lipid mixture (d) in rats on normal chow control diet (CON), high-fat palm oil diet (HFP),
and high-fat lard diet (HFL) (n = 9 per group). H2O, residual water; Cho, choline; IHCL, intrahepatocellular lipids. Data are expressed as mean ± SEM.
* p < 0.05, ** p < 0.01, *** p < 0.001 vs. CON; † p < 0.05 vs. HFP; § p < 0.05, §§ p < 0.01, §§ p < 0.001 vs. 4 h
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AUCi was also higher in both HFP and HFL compared
with CON (p < 0.01). Both high-fat diets led to the devel-
opment of whole-body insulin resistance as indicated by
the higher product of AUCg and AUCi (p < 0.01) and the
higher HOMA-IR index (p < 0.01) in the HFP and HFL
groups compared with CON. However, the measures for
whole-body insulin resistance did not differ between
HFP and HFL.
To determine the glucose tolerance of the liver, 2H2-
glucose was used in the ipGTT. The AUC of plasma
2H2-glucose was higher in HFP compared with CON
(p < 0.05), while it only tended to be higher in HFL
compared with CON (p = 0.066; Table 3). The AUC
of the glucose enrichment (EN) and the maximal EN
did not differ between groups. However, the time to
reach the maximal EN was longer in HFL than in CON
(p < 0.05). Although the difference is small, this shows that
in HFL animals the liver is producing more (unlabeled)
glucose despite increased plasma glucose concentrations,
indicating that the liver of HFL animals is slightly more
glucose intolerant.
Discussion
The present study aimed to elucidate the effects of low-
stearate palm oil and high-stearate lard high-fat diets on
liver lipid metabolism and glucose tolerance. To this
end, Wistar rats were fed with a normal chow control
diet (CON), a high-fat diet based on palm oil (HFP), or a
high-fat diet based on lard (HFL) for a period of
10 weeks. Both high-fat diets resulted in an elevated
IHCL content compared with CON, which was accom-
panied by a delayed uptake and/or slower turnover of
dietary fat in the liver, but without any change in VLDL-
TG secretion rates. Surprisingly, IHCL content was
higher in HFP than in HFL, despite the increased fatty
acid oxidative capacity in isolated liver mitochondria
of HFP animals. In contrast, while both high-fat diets
induced whole-body glucose intolerance, only HFL im-
paired hepatic glucose tolerance.
Ten weeks of HFP and HFL diet feeding in rats
resulted in similar increases in energy intake and body
weight gain compared with CON. In a previous study in
mice using exactly the same diets for a period of 5 weeks,
HFL led to a larger gain in body weight compared
with HFP, which was accompanied by a lower energy
expenditure, mainly due to a significantly lower fatty
Table 2 Oxygen consumption rates in isolated liver
mitochondria oxidizing different substrates in different
metabolic states
CON (n = 9) HFP (n = 9) HFL (n = 9)
Pyruvate +malate (nmol O2 ∙min
-1∙mg protein-1)
State 3 112 ± 7 143 ± 17 110 ± 11
State 4 18 ± 1 33 ± 7 19 ± 2
RCR 5.1 ± 0.5 5.1 ± 0.5 5.8 ± 0.7
Palmitoyl-L-carnitine +malate (nmol O2∙ min
-1∙mg protein-1)
State 3 162 ± 18 232 ± 22 * 193 ± 10
State 4 27 ± 3 30 ± 3 27 ± 3
RCR 6.0 ± 0.3 7.8 ± 1.2 7.9 ± 1.4
Palmitoyl-CoA + L-carnitine +malate (nmol O2 ∙min
-1∙mg protein-1)
State 3 134 ± 20 205 ± 18 * 151 ± 15
State 4 27 ± 5 26 ± 4 31 ± 7
RCR 4.6 ± 0.5 7.0 ± 0.8 * 4.7 ± 0.4 †
Data are expressed as mean ± SEM. CON, normal chow control diet; HFP,
high-fat palm oil diet; HFL, high-fat lard diet; state 3, maximal ADP-stimulated
oxygen consumption; state 4, basal oxygen consumption; RCR, respiratory
control ratio. * p < 0.05 vs. CON; † p < 0.05 vs. HFP
Fig. 3 Hepatic very-low density lipoprotein-triglyceride secretion rate. Fasting plasma TG concentration (a) and rate of hepatic very-low density
lipoprotein-triglyceride (VLDL-TG) secretion (b) in rats on normal chow control diet (CON), high-fat palm oil diet (HFP), and high-fat lard diet (HFL)
(n = 11 per group). Data are expressed as mean ± SEM. ** p < 0.01 vs. CON, † p < 0.05 vs. HFP
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Fig. 4 IpGTT with deuterated glucose. Time course of plasma glucose (n = 11 per group) (a), 2H2-glucose (n = 6 per group) (b), glucose
enrichment (n = 6 per group) (c), and insulin (n = 11 per group) (d) during the ipGTT with deuterated glucose for rats on normal chow control
diet (●), high-fat palm oil diet (∇), and high-fat lard diet ( ). Data are expressed as mean ± SEM. # p < 0.05, ## p < 0.01, ### p < 0.001 vs. HFP and
HFL; † p < 0.05 vs. HFP
Table 3 Plasma glucose and insulin concentrations during ipGTT with deuterated glucose
CON (n = 11) HFP (n = 11) HFL (n = 11)
Fasting glucose (mM) 5.7 ± 0.4 8.0 ± 0.5 ** 7.7 ± 0.3 **
AUCg (mM · h) 15.3 ± 0.5 22.5 ± 0.7 *** 25.6 ± 0.8 ***,††
Fasting insulin (pM) 163 ± 23 438 ± 82 ** 463 ± 34 ***
AUCi (pM · h) 670 ± 65 1622 ± 208 *** 1421 ± 112 **
AUCg*AUCi (mM · h*pM · h) 9138 ± 689 41146 ± 6721 *** 36262 ± 2635 **
HOMA-IR 33.8 ± 4.8 134.8 ± 24.3 ** 171.0 ± 13.3 ***
2H2-glucose concentrations (n = 6 per diet group)
2 · AUCd2g (mM · h) 6.0 ± 1.0 9.6 ± 0.9 * 9.1 ± 2.5
AUCEN (%
2H2-glucose · h) 36.2 ± 4.9 37.5 ± 0.9 34.3 ± 1.0
Maximal EN (% 2H2-glucose) 22.6 ± 2.8 23.2 ± 0.7 20.9 ± 0.6
Time to maximal EN (min) 46.8 ± 4.2 52.8 ± 2.2 58.4 ± 1.6 *
Data are expressed as mean ± SEM. CON, normal chow control diet; HFP, high-fat palm oil diet; HFL, high-fat lard diet; AUCg, area under the glucose curve; AUCi,
area under the insulin curve; HOMA-IR, homeostatic model assessment for insulin resistance; AUCd2g, area under the
2H2-glucose curve (a factor 2 is necessary for
comparison of area under the 2H2-glucose curve to area under the glucose curve because the glucose injected was only 50 % enriched in
2H2-glucose); EN,
glucose enrichment (% 2H2-glucose of total glucose); AUCEN, area under the EN curve. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. CON; †† p < 0.01 vs. HFP
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acid oxidation rate [25]. However, in another study
19 weeks of feeding high-fat diets with palm oil and
lard oil in mice resulted in similar body weight gains
[42]. Besides the differential effects of diets in different
species and strains, also other factors such as starting age
and duration of the diet, stress, and housing conditions
are known to modulate the effects on body weight [43],
which may explain the different results in the various
studies.
Because stearate is inefficiently oxidized by hepato-
cytes [18–21] and because it is a poor substrate for
esterification into TG and subsequent VLDL synthesis
and secretion [22, 23], we hypothesized that HFL would
induce greater hepatic steatosis as compared with HFP.
In contrast, we found that, while both high-fat diets in-
creased IHCL content compared with CON, the increase
in IHCL was larger with HFP than with HFL. Moreover,
we observed no differences in VLDL-TG secretion rates
among the diet groups. We did however find that
HFP feeding upregulated the capacity for fatty acid β-
oxidation in liver mitochondria, as evidenced by the
increased state 3 oxygen consumption rates with the fat-
derived substrates palmitoyl-L-carnitine and palmitoyl-
CoA, but not with the glucose-derived substrate pyruvate.
In contrast, there was no significant effect of HFL feeding
on liver mitochondrial capacity. Interestingly, at the
whole-body level, HFP feeding has been shown to lead to
higher fatty acid oxidation rates as compared with HFL
feeding [25], which corresponds with the greater effects
on liver fatty acid oxidative capacity in HFP animals in the
current study. The increased capacity for fatty acid oxida-
tion upon high-fat diet feeding has been regarded as an
adaptive response to prevent the damaging effects of an
increased influx of fatty acids into the liver [44–46].
However, apparently this adaptation in HFP animals
was insufficient to cope with the dietary lipid overload.
Therefore, we also looked into the time course of up-
take and utilization of dietary lipids in the liver, using in
vivo 1H-[13C] MRS after the oral administration of a
13C-labeled lipid mixture. In CON rats, we observed a 4-
fold increase in the 13C enrichment of the IHCL pool
4 h after 13C-labeled lipid administration (not shown),
which is similar to our earlier results in healthy rats [30]
and which is a measure for the uptake of dietary lipids
by the liver. Thereafter, between 4 and 24 h after 13C-la-
beled lipid administration, 13C-labeled IHCL content
decreased 2.5-fold in CON rats, indicating the turnover
of diet-derived lipids in the liver through oxidation and
secretion [30]. In comparison with CON, the dynamics
of dietary lipid uptake and turnover in the liver was
markedly different in the high-fat diet groups. In the
early postprandial period, 4 h after the administration of
the 13C-labeled lipids, dietary lipid uptake was lower
in both high-fat diet groups compared with CON.
However, between 4 and 24 h the 13C-labeled IHCL con-
tent did not decrease, but further increased, suggesting a
delayed uptake and/or a slower turnover of dietary fat in
the liver after high-fat diet feeding, which may have
contributed to the development of liver steatosis. These
results are in contrast with our findings in other rat
models of liver steatosis, i.e. pre-diabetic and diabetic
obese Zucker diabetic fatty rats, in which liver steatosis
was associated with increased dietary lipid uptake in the
early postprandial period, while the turnover of diet-
derived lipids was largely unaffected [31]. The lower up-
take of 13C-labeled lipids in high-fat diet fed rats in the
early postprandial period could possibly be due to the
higher dilution of the 13C label with the relatively high
amount of unlabeled lipids from the high-fat diets (45
En% from fat) compared with the diets for CON rats
(9 En% from fat) and Zucker diabetic fatty rats (19
En% from fat). However, in other studies it has been
shown that both in type 2 diabetes patients and in
streptozotocin-induced diabetic rats there is a delay
in the removal of chylomicron remnants from the cir-
culation [47–50], which is in agreement with our data
of delayed dietary lipid uptake in the liver of high-fat
diet fed animals. The molecular basis for the defective
clearance of chylomicron remnants in diabetic conditions
has not been elucidated, but it may be induced by insulin
resistance and a consequent down-regulation of the low
density lipoprotein (LDL) receptor, the latter of which is
the primary route for chylomicron remnant removal by
the liver [49, 51]. However, in streptozotocin-induced
diabetic rats the delayed remnant removal seems to be as-
sociated with insulin deficiency rather than insulin resist-
ance, as similar effects were observed with regular and
high-fat diet feeding [50].
We found no major differences in the dynamics of
dietary lipid uptake and turnover in the liver between
the two high-fat diet groups. It should be noted that all
animals received the same 13C-labeled lipid mixture,
which does not match the composition of the different
diets, and that the 1H-[13C] MRS method does not dif-
ferentiate between different fatty acids. Therefore, these
experiments do not provide specific information on the
liver uptake of palmitate versus stearate, which is a limi-
tation of the study. Stearate is poorly absorbed from the
gut [52]; however, intestinal absorbability of stearate is
similar to that of palmitate [53] and therefore the greater
IHCL accumulation with HFP compared with HFL is
not likely caused by differences in absorption. The in-
crease in 13C-labeled IHCL content between 4 and 24 h
after 13C-labeled lipid administration tended to be higher
in HFP than in HFL (p = 0.07; Fig. 2d). Therefore the
increased IHCL accumulation in HFP as compared with
HFL may be associated with an increased uptake of diet-
ary fat during the late postprandial period. Moreover,
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fasting plasma TG levels were higher in HFP than in HFL,
which may have contributed to the higher IHCL accu-
mulation in HFP through a mass action effect. Finally,
increased de novo lipogenesis could also be a mechanism
for the greater IHCL accumulation in HFP as compared
with HFL, but to the best of our knowledge, there is
no literature data on differential effects of low-stearate
versus high-stearate diets on de novo lipogenesis in the
liver.
Both high-fat diets induced hyperglycemia, hyperinsuli-
nemia, whole-body glucose intolerance, and whole-body
insulin resistance, but the impairment of whole-body
glucose tolerance (determined from the AUCg during the
ipGTT) was slightly greater in HFL than in HFP. More-
over, the deuterated glucose tolerance test showed that in
HFL animals the liver produces more (unlabeled) glucose
despite increased plasma glucose concentrations, which
indicates that in HFL animals the liver is more glucose
intolerant than in CON and HFP animals. This is in agree-
ment with the study of van den Berg et al., in which mice
receiving a HFL diet developed both hepatic and periph-
eral insulin resistance, while mice fed with a HFP diet only
developed peripheral insulin resistance [25]. Our findings
question the role of IHCL in the development of liver in-
sulin resistance [26], as HFP feeding resulted in a greater
accumulation of IHCL than with HFL feeding, but without
any signs of liver glucose intolerance. However, the greater
IHCL accretion in HFP was accompanied by an increased
mitochondrial capacity for fatty acid oxidation in the liver,
which may have prevented the accumulation of toxic,
lipid-derived intermediates, such as diacylglycerols, ex-
plaining the absence of lipid-induced glucose intolerance
in the liver of HFP animals [26]. Alternatively, the slight
impairment of hepatic glucose tolerance with HFL may be
explained by specific effects of stearate on pathways inter-
secting with the insulin signaling pathway [54–57] or by
its effects on membrane rigidity and insulin signal trans-
duction [58–60].
Conclusion
In conclusion, both high-fat diets based on palm oil and
lard induced liver lipid accumulation, which was accom-
panied by a delayed uptake and/or slower turnover of diet-
ary fat in the liver without any effects on VLDL secretion.
However, despite the even larger accretion of lipids in the
liver with the high-fat palm oil diet, only the high-fat lard
diet impaired hepatic glucose tolerance.
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